INTRODUCTION {#sec1}
============

Mesenchymal chondrosarcoma (MCS) is a rare high-grade sarcoma of bone and soft tissue firstly described by Lightenstein and Bernstein in 1959 \[[@ref1]\].

MCS has a highly aggressive behavior and accounts for approximately 3% of all chondrosarcoma, with a peak incidence in the second and third decades \[[@ref2]\].

MCS is composed of undifferentiated neoplastic cells associated with areas of mature cartilage and usually a hemangiopericytoma-like pattern of vascularization. Up to one-third of cases of MSC arise primarily in the soft tissue, with approximately 30 cases of orbital MSC described in the literature. Here, we report a case with primary orbital MCS in a 30 year-old patient, an entity that should be considered in the differential diagnosis of calcified orbital lesions.

CASE REPORT {#sec2}
===========

A 30-year-old Caucasian female without any past medical illness presented with an endorbital mass of the right eye, without proptosis. Physical examination revealed a decreased right visual acuity. No abnormality of the left eye was detected. Computed tomography (CT) and magnetic resonance imaging (MRI) scans revealed a well-defined right intrasonic mass, in the upper-external quadrant with optical nerve displacement without involvement of it. The endorbital mass was adherent to the superior rectus muscle with a cleavage plane. CT scans demonstrated an ovoidal soft tissue mass with central calcification. T1 and T2 weighted images showed an oval tumor with iso-hyperintense signal with a calcified central component. Enhanced T2 weighted images demonstrated an omogenous tumoral enhancement except for the central calcified part ([Fig. 1](#f1){ref-type="fig"}). These findings have led to a radiological-suggested differential diagnosis between vascular malformation, cavernous hemangioma and solitary fibrous tumor.

![(**A--D**) Imaging features of MCS: CT scans demonstrated an ovoidal soft tissue mass with central calcification (A), T2 (B) and T1 (C) weighted images showing an oval tumor with iso-hyperintense signal with a calcified central component. Enhanced T1 weighted image demonstrating an omogenous tumoral enhancement except for the central calcified part (D).](rjaa037f1){#f1}

An excisional biopsy of the orbital mass was performed. We found a firm, whitish nodule that measured 2.8 × 1.9 × 1.7 cm. Microscopically, the neoplasm had a typical biphasic pattern, with a hypercellular small round cell component intermixed with islands of well-differentiated cartilage showing metaplastic bone ossification. There was an abrupt transition between the two different components of the neoplasm, and a hemangiopericytoma-like vascular pattern was noted ([Figs 2](#f2){ref-type="fig"}--[4](#f4){ref-type="fig"}). Immunohistochemically, the mesenchymal small cell component showed focal cytoplasmic positivity for CD99, while the cartilaginous component was S100 protein-positive ([Figs 5](#f5){ref-type="fig"} and [6](#f6){ref-type="fig"}). The neoplastic cells showed negativity for cytokeratin AE1/AE3, STAT6 (signal transducer and activator of transcription-6), CD31 and CD34. The findings were consistent with MCS. This case was sent for a second opinion to Prof. Angelo Paolo Dei Tos (Department of Pathology, Azienda ULSS 2 Marca Trevigiana, Treviso, Italy) who confirmed the diagnosis of MCS, also reporting nuclear positivity for SOX9, a master regulator of the differentiation of mesenchymal cells into chondrocytes.

![Low-power view of the lesion showing central ossification (H&E).](rjaa037f2){#f2}

![Abrupt transition from small cell component to well differentiated cartilaginous area (H&E, high power view).](rjaa037f3){#f3}

![Typical hemangiopericytoma-like vascular pattern (H&E, high power view).](rjaa037f4){#f4}

![Immunohistochemical features of MCS: cytoplasmic positivity for CD99 in the small cell component (IHC stain).](rjaa037f5){#f5}

![Nuclear positivity for S100 in the cartilaginous component (IHC stain).](rjaa037f6){#f6}

DISCUSSION {#sec3}
==========

Clinically, the patient did not present with proptosis, a very common finding in orbital chondrosarcoma patients \[[@ref3]\]. Similar to previous reports \[[@ref4]\], we observed ossification of the orbital mass, a characteristic TC finding of orbital chondrosarcoma \[[@ref4], [@ref5]\].

We also observed optic nerve displacement that is a common finding in intraorbital MCS. Optic nerve tissue involvement, which has rarely been reported in huge tumors associated with intracranial extension \[[@ref7]\], was not seen.

In our case, nuclear positivity for Sox9 was reported. This immunohistochemical finding could be useful to distinguish this entity from other small round cell tumors \[[@ref8]\]. In addition, molecular studies have demonstrated a recurrent HEY1-NCOA2 fusion in MSC \[[@ref9]\], which could support the diagnosis of this tumor. In conclusion, although orbital MSC is a rare entity, it should be considered in calcified lesions affecting children and young adults.
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